NDC 0310-0095 – Daliresp
Roflumilast 500 ug/1 · Tablet · Oral
Product NDC0310-0095
Product details
- Brand name
- Daliresp
- Generic name
- Roflumilast
- Labeler
- AstraZeneca Pharmaceuticals LP
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- NDA · NDA022522
- Marketed since
- July 1, 2015
- Listing expires
- December 31, 2026
- Pharmacologic class
- Phosphodiesterase 4 Inhibitor
Active ingredients
- Roflumilast 500 ug/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0310-0095-30 | 30 TABLET in 1 BOTTLE, PLASTIC (0310-0095-30) | Jul 1, 2015 |
| 0310-0095-90 | 90 TABLET in 1 BOTTLE, PLASTIC (0310-0095-90) | Jul 1, 2015 |
Other Daliresp products
- 0310-0088 Roflumilast 250 ug/1 · Tablet · AstraZeneca Pharmaceuticals LP